EDITAS MEDICINE INC (EDIT) Forecast, Price Target & Analyst Ratings

NASDAQ:EDIT • US28106W1036

2.44 USD
-0.1 (-3.94%)
At close: Mar 13, 2026
2.46 USD
+0.02 (+0.82%)
After Hours: 3/13/2026, 8:22:26 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EDITAS MEDICINE INC (EDIT).

Forecast Snapshot

Consensus Price Target

Price Target
$5.32
+ 117.97% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release DateMay 11, 2026
PeriodQ1 / 2026
EPS Estimate-$0.30
Revenue Estimate2.623M
 → Full earnings forecast details

ChartMill Buy Consensus

Rating
74.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$5.32
Upside
+ 117.97%
From current price of $2.44 to mean target of $5.32, Based on 20 analyst forecasts
Low
$1.01
Median
$4.08
High
$13.65

Price Target Revisions

1 Month
0.00%
3 Months
7.51%

Price Target Summary

20 Wall Street analysts provided a forecast for the next 12 months for EDIT. The average price target is 5.32 USD. This implies a price increase of 117.98% is expected in the next year compared to the current price of 2.44.
The average price target has been revised upward by 7.51% in the past 3 months.
 → Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

EDIT Current Analyst RatingEDIT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

EDIT Historical Analyst RatingsEDIT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
74.00%
EDIT was analyzed by 20 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about EDIT.
In the previous month the buy percentage consensus was at a similar level.
EDIT was analyzed by 20 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-10Jones TradingUpgrade Hold -> Buy
2026-03-09Chardan CapitalMaintains Buy -> Buy
2025-09-05HC Wainwright & Co.Reiterate Buy -> Buy
2025-09-03Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-08-15HC Wainwright & Co.Maintains Buy -> Buy
2025-08-13BairdMaintains Outperform -> Outperform
2025-05-13BairdMaintains Outperform -> Outperform
2025-04-28HC Wainwright & Co.Initiate Buy
2024-12-16Evercore ISI GroupMaintains Outperform -> Outperform
2024-12-16JP MorganDowngrade Neutral -> Underweight
2024-12-13Chardan CapitalDowngrade Buy -> Neutral
2024-12-13RBC CapitalMaintains Sector Perform -> Sector Perform
2024-12-13StifelDowngrade Buy -> Hold
2024-12-13BarclaysMaintains Equal-Weight -> Equal-Weight
2024-12-13BairdMaintains Outperform -> Outperform
2024-12-11Wells FargoDowngrade Overweight -> Equal-Weight
2024-11-05Chardan CapitalMaintains Buy -> Buy
2024-11-05RBC CapitalMaintains Sector Perform -> Sector Perform
2024-11-05StifelMaintains Buy -> Buy
2024-11-05BarclaysMaintains Equal-Weight -> Equal-Weight
2024-11-05Wells FargoMaintains Overweight -> Overweight
2024-11-05Truist SecuritiesMaintains Buy -> Buy
2024-10-23Wells FargoMaintains Overweight -> Overweight
2024-10-23Evercore ISI GroupMaintains In-Line -> In-Line
2024-10-22Chardan CapitalMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release DateMay 11, 2026
PeriodQ1 / 2026
EPS Estimate-$0.30
Revenue Estimate2.623M
Revenue Q2Q-43.69%
EPS Q2Q67.92%
Number of Analysts11

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
22.97%
EPS (1 Month)
0.00%
EPS (3 Months)
2.41%

Next Earnings Summary

EDIT is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.3 USD and the consensus revenue estimate is 2.62M USD.
The next earnings revenue estimate has been revised upward by 22.97% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
 → Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
EDIT revenue by date.EDIT revenue by date.
78.123M
296.36%		32.314M
-58.64%		40.52M
25.39%		14.403M
-64.45%		12.896M
-10.46%		11.475M
-11.02%		8.5M
-25.93%		22.78M
168.00%		71.91M
215.67%		124.95M
73.76%		186.15M
48.98%
EBITDA
YoY % growth
EDIT ebitda by date.EDIT ebitda by date.
-163.117M
25.72%		-233.111M
-42.91%		N/A
27.58%		-126.983M
24.78%		-140.586M
-10.71%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
EDIT ebit by date.EDIT ebit by date.
-169.181M
25.12%		-238.92M
-41.22%		-99.336M
58.42%		-119.722M
-20.52%		-143.591M
-19.94%		-164.969M
-14.89%		-170.17M
-3.15%		-175.78M
-3.30%		-167.79M
4.55%		-131.58M
21.58%		-86.7M
34.11%
Operating Margin
EDIT operating margin by date.EDIT operating margin by date.
-216.56%-739.37%-245.15%-831.23%-1,113.45%-1,437.64%-2,002.00%-771.64%-233.33%-105.31%-46.58%
EPS
YoY % growth
EDIT eps by date.EDIT eps by date.
-2.05
36.14%		-2.88
-40.49%		-1.89
34.37%		-1.16
38.73%		-1.02
12.31%		-1.08
-6.81%		-1.03
5.01%		-0.96
6.93%		-0.66
30.85%		-0.17
73.85%		0.41
335.29%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.30
67.92%		-0.28
55.45%		-0.32
-14.07%		-0.26
-327.26%
Revenue
Q2Q % growth		2.623M
-43.69%		1.483M
-58.55%		2.171M
-71.22%		8.629M
-65.12%
EBITDA
Q2Q % growth		-32.851M
1.62%		-33.649M
-54.98%		-34.465M
-71.67%		N/A
EBIT
Q2Q % growth		-30.279M
14.25%		-26.201M
-2.90%		-30.83M
-25.59%		-24.886M
-77.56%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

EDIT Yearly Revenue VS EstimatesEDIT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50M 100M 150M
EDIT Yearly EPS VS EstimatesEDIT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -5 -10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
12.56%
EPS Next 5 Year
8.34%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-18.78%
Revenue Next 5 Year
1.24%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

EDITAS MEDICINE INC / EDIT Forecast FAQ

What do analysts expect the price target to be for EDITAS MEDICINE INC (EDIT)?

20 analysts have analysed EDIT and the average price target is 5.32 USD. This implies a price increase of 117.98% is expected in the next year compared to the current price of 2.44.


What is the next earnings date for EDIT stock?

EDITAS MEDICINE INC (EDIT) will report earnings on 2026-05-11.


What are the consensus estimates for EDITAS MEDICINE INC (EDIT) next earnings?

The consensus EPS estimate for the next earnings of EDITAS MEDICINE INC (EDIT) is -0.3 USD and the consensus revenue estimate is 2.62M USD.


How do analysts rate EDITAS MEDICINE INC (EDIT)?

The consensus rating for EDITAS MEDICINE INC (EDIT) is 74 / 100 . This indicates that analysts generally have a positive outlook on the stock.